Parisa Tajdini
1,2, Majid Foroutan
3,4* 
1 Department of Pediatrics, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
2 Clinical Research Development Unit, Amir-Al-Momenin Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran
3 Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran
4 Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran
Abstract
Oncohypertension is a relatively recent concept that refers to the development of elevated blood pressure in patients with cancer, which is driven by the tumor itself. This review article aims to provide an overview of oncohypertension, including its pathophysiology, clinical implications, diagnostic approaches, and management strategies. The study discusses the association between oncological disorders and hypertension, highlighting the underlying mechanisms responsible for the development of oncohypertension. Furthermore, various diagnostic methods, including imaging techniques and laboratory tests, are discussed in detail. Finally, treatment options for oncohypertension, including both pharmacological and non-pharmacological approaches, are thoroughly reviewed to optimize blood pressure control and improve patient outcomes
Implication for health policy/practice/research/medical education:
Oncohypertension refers to the development of high blood pressure in cancer patients. Oncohypertension is a complex condition that requires a comprehensive understanding of the relationship between hypertension and cancer, the effects of anti-cancer agents on blood pressure, and the management of hypertension in cancer patients.
Please cite this paper as: Tajdini P, Foroutan M. On the occasion of World Cancer Day 2024; focus on hypertension and anticancer agents. J Renal Inj Prev. 2024; x(x): e32259. doi: 10.34172/jrip.2024.32259.